BOLT BIOTHERAPEUTICS INC's ticker is BOLT and the CUSIP is 097702104. A total of 36 filers reported holding BOLT BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $50,686 | -18.8% | 48,737 | 0.0% | 0.00% | – |
| Q2 2023 | $62,383 | -7.9% | 48,737 | 0.0% | 0.00% | – |
| Q1 2023 | $67,744 | -46.5% | 48,737 | -50.0% | 0.00% | – |
| Q4 2022 | $126,716 | +76.0% | 97,474 | +100.0% | 0.00% | – |
| Q3 2022 | $72,000 | -27.3% | 48,737 | 0.0% | 0.00% | – |
| Q2 2022 | $99,000 | -88.7% | 48,737 | -84.7% | 0.00% | – |
| Q1 2022 | $874,000 | -43.1% | 318,886 | +1.8% | 0.00% | – |
| Q4 2021 | $1,535,000 | -56.8% | 313,207 | +11.6% | 0.00% | – |
| Q3 2021 | $3,550,000 | +9.7% | 280,666 | +34.0% | 0.00% | – |
| Q2 2021 | $3,237,000 | -43.1% | 209,388 | +21.1% | 0.00% | – |
| Q1 2021 | $5,692,000 | – | 172,964 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 1,891,467 | $29,242,000 | 11.52% |
| Nan Fung Group Holdings Ltd | 1,166,952 | $18,041,000 | 5.60% |
| Novo Holdings A/S | 4,503,991 | $69,632,000 | 3.09% |
| Vivo Capital, LLC | 3,871,291 | $59,850,000 | 2.59% |
| Sofinnova Investments, Inc. | 2,754,437 | $42,584,000 | 2.45% |
| Ally Bridge Group (NY) LLC | 412,267 | $6,374,000 | 1.58% |
| Samsara BioCapital, LLC | 737,459 | $11,401,000 | 1.41% |
| Board of Trustees of The Leland Stanford Junior University | 719,546 | $11,125,000 | 1.04% |
| RA Capital Management | 2,378,325 | $36,769,000 | 0.59% |
| Rock Springs Capital Management LP | 1,619,248 | $25,034,000 | 0.50% |